BREVICON 1/35 21 TAB DIN 00531006
Health Canada record
| Active ingredient(s) | NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G03AA05 NORETHISTERONE AND ESTROGEN |
| Original market date | 31-Dec-1982 |
| Current status date | 30-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Syntex S.A. — licence , not currently licensed, last inspection rating I (2025-11-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NORETHINDRONE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02189054 | BREVICON 1/35 TABLETS (21-DAY PACK) | PFIZER CANADA ULC | Tablet | NORETHINDRONE 1 MG; ETHINYL ESTRADIOL 0.035 MG | Marketed |
| 02189062 | BREVICON 1/35 TABLETS (28-DAY PACK) | PFIZER CANADA ULC | Tablet | NORETHINDRONE 1 MG; ETHINYL ESTRADIOL 0.035 MG | Marketed |
| 02441306 | JENCYCLA | LUPIN PHARMA CANADA LIMITED | Tablet | NORETHINDRONE 0.35 MG | Marketed |
| 02458683 | MAEVE | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | NORETHINDRONE 0.35 MG | Marketed |
| 02410303 | MOVISSE | SENADOR LABORATORIES PRIVATE LIMITED | Tablet | NORETHINDRONE 0.35 MG | Marketed |
| 02197502 | SELECT 1/35 (21-DAY) | PFIZER CANADA ULC | Tablet | NORETHINDRONE 1.0 MG; ETHINYL ESTRADIOL 0.035 MG | Marketed |
| 02199297 | SELECT 1/35 (28-DAY) | PFIZER CANADA ULC | Tablet | NORETHINDRONE 1.0 MG; ETHINYL ESTRADIOL 0.035 MG | Marketed |
| 02187108 | SYNPHASIC 21 TABLETS | PFIZER CANADA ULC | Tablet | NORETHINDRONE 0.5 MG; ETHINYL ESTRADIOL 0.035 MG; NORETHINDRONE 1.0 MG; ETHINYL ESTRADIOL 0.035 MG | Marketed |
| 02187116 | SYNPHASIC 28 TABLETS | PFIZER CANADA ULC | Tablet | NORETHINDRONE 0.5 MG; ETHINYL ESTRADIOL 0.035 MG; NORETHINDRONE 1.0 MG; ETHINYL ESTRADIOL 0.035 MG | Marketed |
| 00531014 | BREVICON 1/35 28 TAB | SYNTEX INC. | Tablet | NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 02435659 | GENERESS | ALLERGAN INC | Tablet (Chewable) | NORETHINDRONE 0.8 MG; ETHINYL ESTRADIOL 0.025 MG | Cancelled Pre Market |
| 00037605 | MICRONOR TABLETS 28-DAY | JANSSEN INC | Tablet | NORETHINDRONE 0.35 MG | Cancelled Post Market |
| 02188724 | NORINYL 1/50 -(21-DAY REGIMEN) | PFIZER CANADA ULC | Tablet | NORETHINDRONE 1 MG; MESTRANOL .05 MG | Cancelled Post Market |
| 02188732 | NORINYL 1/50 -(28-DAY REGIMEN) | PFIZER CANADA ULC | Tablet | NORETHINDRONE 1 MG; MESTRANOL 0.05 MG | Cancelled Post Market |
| 00030333 | NORINYL 1/50 21 TAB | SYNTEX INC. | Tablet | NORETHINDRONE 1 MG; MESTRANOL .05 MG | Cancelled Post Market |
| 00340847 | NORINYL 1/50 28 TAB | SYNTEX INC. | Tablet | NORETHINDRONE 1 MG; MESTRANOL .05 MG | Cancelled Post Market |
| 00340731 | ORTHO 0.5/35 TABLETS (28 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 0.5 MG; ETHINYL ESTRADIOL 0.035 MG | Cancelled Post Market |
| 00372846 | ORTHO 1/35 TABLETS (21 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00372838 | ORTHO 1/35 TABLETS (28 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 1 MG; ETHINYL ESTRADIOL .035 MG | Cancelled Post Market |
| 00602957 | ORTHO 7/7/7 TABLETS (21 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 0.5 MG; ETHINYL ESTRADIOL 0.035 MG; NORETHINDRONE 0.75 MG; ETHINYL ESTRADIOL 0.035 MG; NORETHINDRONE 1 MG; ETHINYL ESTRADIOL 0.035 MG | Cancelled Post Market |
| 00602965 | ORTHO 7/7/7 TABLETS (28 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 0.5 MG; ETHINYL ESTRADIOL 0.035 MG; NORETHINDRONE 0.75 MG; ETHINYL ESTRADIOL 0.035 MG; NORETHINDRONE 1 MG; ETHINYL ESTRADIOL 0.035 MG | Cancelled Post Market |
| 00022608 | ORTHO-NOVUM 1/50 TABLETS (21 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 1 MG; MESTRANOL .05 MG | Cancelled Post Market |
| 00340758 | ORTHO-NOVUM 1/50 TABLETS (28 DAY) | JANSSEN INC | Tablet | NORETHINDRONE 1 MG; MESTRANOL .05 MG | Cancelled Post Market |
International API supply for NORETHINDRONE
14 active FDA Drug Master Files.
Request a quote for BREVICON 1/35 21 TAB